BioVac - Pfizer
Sector: Manufacturing (Industrial) • Location: South Africa
Source: IFC Project Disclosures
The proposed IFC investment seeks to support, the Biologicals and Vaccines Institute of Southern Africa ('BioVac' or the 'Company'), a South African biopharmaceutical company based in Cape Town, to expand its suite of products which includes partnering with Pfizer-BioNTech through a tech transfer agreement for fill and finish manufacturing of vaccines on the continent thus helping reduce Africa’s
- Status
- Prospective
- Sector
- Manufacturing (Industrial)
- Location
- South Africa
- Updated
- 19 Nov 2026
- Source
- IFC Project Disclosures
ConstructChat
Ask ConstructChat about BioVac - Pfizer
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | active |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | The proposed IFC investment seeks to support, the Biologicals and Vaccines Institute of Southern Africa ('BioVac' or the 'Company'), a South African biopharmaceutical company based in Cape Town, to expand its suite of products which includes partnering with Pfizer-BioNTech through a tech transfer agreement for fill and finish manufacturing of vaccines on the continent thus helping reduce Africa’s over dependence on imported vaccines (the Project). |
Original sector | other |
Location
Country | South Africa |
Source
Source | IFC Project Disclosures |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial) |
Article published date | 2026-09-09 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
